Skip to main content

Table 2 Use the expression levels of circPTPN22, CEA, and CA199 to distinguish gastric cancer patients from healthy donors

From: As a biomarker for gastric cancer, circPTPN22 regulates the progression of gastric cancer through the EMT pathway

 

SEN, %

SPE, %

ACCU, %

PPV, %

NPV, %

CircPTPN22

0.78 (93/120)

0.84 (87/104)

0.80 (180/224)

0.85 (93/110)

0.76 (87/114)

CEA

0.75 (90/120)

0.68 (71/104)

0.72 (161/224)

0.73 (90/123)

0.70 (71/101)

CA199

0.71 (85/120)

0.40 (42/104)

0.57 (127/224)

0.58 (85/147)

0.55 (42/77)

CircPTPN22 + CEA

0.82 (98/120)

0.81 (84/104)

0.81 (182/224)

0.83 (98/118)

0.72 (84/116)

CircPTPN22 + CEA + CA199

0.83 (99/120)

0.87 (90/104)

0.84 (189/224)

0.88 (99/113)

0.81 (90/111)